2.39 Effectiveness of Newer-Generation Antidepressants with Dr. Michael Hengartner

OncologyMedicineHealth Policy
Written By Kerrington .
Episode 2.39 Show Notes

Our guest this week is Dr. Michael Hengartner of the Zurich University of Applied Sciences. We interview him on his work studying the long-term consequences and effectiveness of newer-generation antidepressants - specifically focusing on selective serotonin reuptake inhibitors (SSRIs).

Kerrington .
Previous

2.40 BEACON part 2, NALA, & Molecular Pathology and Next-Generation Sequencing with Dr. David Carr
Next

2.38 KEYNOTE-048, Academic Currency, & Trials in Low/Mid-Income Countries with Dr. Bishal Gyawali